NEO · Neogenomics Inc · Insider Trading

Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection with the September 1, 2026 vesting of restricted stock.

On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Reflects release of restricted stock units that were previously reported on a Form 4.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Reflects release of restricted stock units that were previously reported on a Form 4.

Once vested, the shares of common stock are not subject to expiration.

Reflects release of restricted stock units that were previously reported on a Form 4.

Reflects release of restricted stock units that were previously reported on a Form 4.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

Reflects the release of restricted stock units that were previously reported on a Form 4.

Once vested, the shares of common stock are not subject to expiration.

Reflects the release of restricted stock units that were previously reported on a Form 4.

Reflects release of restricted stock units that were previously reported on a Form 4.

Reflects release of restricted stock units that were previously reported on a Form 4.

Once vested, the shares of common stock are not subject to expiration.

Once vested, the shares of common stock are not subject to expiration.

On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

Once vested, the shares of common stock are not subject to expiration.

On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

Once vested, the shares of common stock are not subject to expiration.

Reflects the release of restricted stock units that were previously reported on a Form 4.

Each restricted stock unit is the economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting.

Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

Reflects the release of restricted stock units that were previously reported on a Form 4.

Each restricted stock unit is economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting.